Latest & greatest articles for heart failure

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on heart failure or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on heart failure and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for heart failure

101. The efficacy and safety of sacubitril/valsartan in the treatment of patients with heart failure with reduced left ventricular ejection fraction: a systematic review and meta-analysis

The efficacy and safety of sacubitril/valsartan in the treatment of patients with heart failure with reduced left ventricular ejection fraction: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

102. What are the effects of nutritional interventions on outcomes in patients with heart failure with preserved ejection fraction (HFpEF)?

What are the effects of nutritional interventions on outcomes in patients with heart failure with preserved ejection fraction (HFpEF)? Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

103. Examining the physiological and psychological outcomes of high intensity interval training in heart failure patients: a systematic review

Examining the physiological and psychological outcomes of high intensity interval training in heart failure patients: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

104. Levosimendan in acute heart failure by acute coronary syndrome

Levosimendan in acute heart failure by acute coronary syndrome Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2019 PROSPERO

105. Herbal medicine (lingui zhugan decoction) for treating chronic heart failure: a systematic review of randomized controlled trials

Herbal medicine (lingui zhugan decoction) for treating chronic heart failure: a systematic review of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

106. Epicardial adipose tissue and heart failure: a systematic review and meta-analysis

Epicardial adipose tissue and heart failure: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

107. Heart failure - chronic

Heart failure - chronic Heart failure - chronic - NICE CKS Share Heart failure - chronic: Summary Heart failure is a complex syndrome in which the ability of the heart to maintain the circulation of blood is impaired as a result of a structural or functional impairment of ventricular filling or ejection. This results in symptoms including breathlessness, fluid retention, and fatigue; and signs including basal crepitations, and peripheral oedema. Heart failure is classified into two main (...) categories with either a reduced or preserved ejection fraction. Symptoms are classified according to severity using the New York Heart Association (NYHA) functional classification. The most common underlying cause is coronary artery disease. Complications include arrhythmias, depression, cachexia, chronic kidney disease, sexual dysfunction, and sudden cardiac death. About 50% of people with heart failure die within 5 years of diagnosis, and about 40% of people admitted to hospital with heart failure die

2019 NICE Clinical Knowledge Summaries

108. Effect of immunomodulation on heart failure: a meta-analysis of randomized control trials

Effect of immunomodulation on heart failure: a meta-analysis of randomized control trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

109. Quality of life impact of pharmacotherapy for heart failure with reduced ejection fraction: systematic review and meta-analysis

Quality of life impact of pharmacotherapy for heart failure with reduced ejection fraction: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

110. Efficacy and safety of Xa inhibitors in patients with heart failure but without long-term anticoagulation: a meta-analysis of randomized controlled trials

Efficacy and safety of Xa inhibitors in patients with heart failure but without long-term anticoagulation: a meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

111. Efficacy and safety of Xa inhibitors in patients with heart failure and coronary or peripheral artery disease: a meta-analysis of randomized controlled trials

Efficacy and safety of Xa inhibitors in patients with heart failure and coronary or peripheral artery disease: a meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

112. Effects of high quality nursing care (HQNC) on psychological intervention (PCI) in patients with chronic heart failure (CHF): a systematic review protocol

Effects of high quality nursing care (HQNC) on psychological intervention (PCI) in patients with chronic heart failure (CHF): a systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

113. A systematic review on disease management programs for heart failure with primary care involvement

A systematic review on disease management programs for heart failure with primary care involvement Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

114. Prognostic value of lung ultrasound in heart failure: a systematic review and meta-analysis

Prognostic value of lung ultrasound in heart failure: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

115. Long-term and short-term prognosis of heart failure patients with mid-range ejection fractions: a meta-analysis

Long-term and short-term prognosis of heart failure patients with mid-range ejection fractions: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

116. Meta-analysis of the effect of educational interventions on knowledge and self-care behaviors to improve clinical outcomes in patients with heart failure

Meta-analysis of the effect of educational interventions on knowledge and self-care behaviors to improve clinical outcomes in patients with heart failure Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

117. Implantable device monitoring versus usual care for managing individuals with heart failure [Cochrane protocol]

Implantable device monitoring versus usual care for managing individuals with heart failure [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

118. Heart failure and cognitive ability: a systematic review and meta-analysis

Heart failure and cognitive ability: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

119. Efficacy of urapidil for senile hypertension (SH) and acute heart failure (AHF): a systematic review of randomized controlled trials

Efficacy of urapidil for senile hypertension (SH) and acute heart failure (AHF): a systematic review of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

120. Efficacy of sacubitril valsartan sodium tablet (SVST) for the treatment of chronic heart failure (CHF): a systematic review of randomized controlled trials

Efficacy of sacubitril valsartan sodium tablet (SVST) for the treatment of chronic heart failure (CHF): a systematic review of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO